Literature DB >> 16909441

Potential medicinal plants for CNS disorders: an overview.

Vikas Kumar1.   

Abstract

Although very few drugs are currently approved by regulatory authorities for treating multi-factorial ailments and disorders of cognition such as Alzheimer's disease, certain plant-derived agents, including, for example, galantamine and rivastigmine (a semi-synthetic derivative of physostigmine) are finding an application in modern medicine. However, in Ayurveda, the Indian traditional system of medicine which is more than 5000 years old, selected plants have long been classified as 'medhya rasayanas', from the Sanskrit words 'medhya', meaning intellect or cognition, and 'rasayana', meaning 'rejuvenation'. These plants are used both in herbal and conventional medicine and offer benefits that pharmaceutical drugs lack. In the present article, an attempt has been made to review the most important medicinal plants, including Ginkgo biloba, St John's wort, Kava-kava, Valerian, Bacopa monniera and Convolvulus pluricaulis, which are widely used for their reputed effectiveness in CNS disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909441     DOI: 10.1002/ptr.1970

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  45 in total

Review 1.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

2.  Differential regulation of calcium signalling pathways by components of Piper methysticum ('Awa).

Authors:  L M N Shimoda; A Showman; J D Baker; I Lange; D L Koomoa; A J Stokes; R P Borris; H Turner
Journal:  Phytother Res       Date:  2015-01-30       Impact factor: 5.878

Review 3.  Plant-based Rasayana drugs from Ayurveda.

Authors:  Subramani Paranthaman Balasubramani; Padma Venkatasubramanian; Subrahmanya Kumar Kukkupuni; Bhushan Patwardhan
Journal:  Chin J Integr Med       Date:  2011-03-09       Impact factor: 1.978

Review 4.  Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

Review 5.  Novel therapeutic approaches: Rett syndrome and human induced pluripotent stem cell technology.

Authors:  Mohan Gomathi; Vellingiri Balachandar
Journal:  Stem Cell Investig       Date:  2017-03-02

Review 6.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

7.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

8.  Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

9.  Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders.

Authors:  Helen Lavretsky
Journal:  Aging health       Date:  2009-02-01

Review 10.  [The influence of diet on mental health].

Authors:  C Hausteiner; S Bornschein; T Zilker; H Förstl; J Grassmann
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.